Bell Potter have 12 month target at $17.12 - that was assuming the trials would be negative. They changed there recommendation from Buy to hold on 10th May.
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
